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Abstract:  
Aim: To develop and preliminarily evaluate a new screening instrument for Atypical 
Odontalgia (AO) or Persistent Dentoalveolar Pain Disorder (PDAP).  To evaluate  the 
instrument’s performance in detecting AO/PDAP amongst a heterogeneous group of orofacial 
pain conditions and pain-free controls and empirically compare its performance with an 
established neuropathic screening instrument (S-LANSS) which is the best available 
standard. 
Methods: The study design was cross-sectional; subjects recruited included a convenience 
sample of pain free controls (n=21) and four groups of orofacial pain conditions: AO/PDAP 
(n=22); Trigeminal Neuralgia (n=21); Temporomandibular Disorder (n=41); and Acute Dental 
Pain (n=41). The instrument’s internal reliability and factor structure were examined alongside 
its sensitivity and specificity and ROC-determined threshold score.  
Results:  The 9 AO/PDAP specific items were found to moderately correlate with the S-
LANSS (r=0.58; p<0.01). The 14-items of the full instrument were examined using exploratory 
factor analysis and reduced to ten items in a two-factor structure that explained 96% of the 
variance. This 10-item final instrument had a ROC area of 0.77 (95% CI: 0.67; 0.88), 
sensitivity of 77% (95%CI: 55; 92%), and specificity of 69% (95%CI: 60; 77%) with an 
intentionally higher false-positive rate than false-negative rate. In contrast, the S-LANSS 
exhibited sensitivity of 32% (95%CI: 14;55%) and specificity of 78% (95%CI: 70;85%) with 
less-optimal false-positive versus false-negative rates.  
Conclusion: This preliminary study shows the new screening instrument for AO/PDAP merits 
progression to field testing.    
  
Introduction 
Pain related to the teeth (odontogenic pain) is the most common orofacial 
pain, estimated to affect between 8-12% of individuals in developed countries 
(Lipton et al. 1993, Steele et al. 2011). Odontogenic pain is primarily 
inflammatory in nature (Berman & Rotstein 2016) and the underlying dental 
disease that produces odontogenic pain often necessitates an invasive 
procedure resulting in deafferentation, e.g. root canal treatment or tooth 
extraction. Both root canal treatment and extraction are common practice in 
developed countries:  U.S. ~20 million endodontic procedures and ~55 million 
tooth extractions (American Dental Association Survey 2007); U.K. ~600,000 
endodontic procedures and ~1.3 million extractions (NHSDigital 2016).  
 
Dental treatments requiring deafferentation result in a small number of 
patients experiencing persistent, post-procedural, non-odontogenic pain 
localised in the tooth site (Marbach 1993, Nixdorf et al. 2012). Uncertainty 
exists whether this pain was actually present before the deafferentation 
procedure due to reports of the phenomenon in the absence of 
deafferentation (Schnurr & Brooke 1992, Ram et al. 2009) . When this 
phenomenon follows a deafferentation procedure it is presumed to be largely 
of neuropathic origin (Baad-Hansen 2008) and has been referred to variously 
as: atypical odontalgia (AO) (Woda & Pionchon 1999, IHS 2004, Ram et al. 
2009), Persistent DentoAlveolar Pain disorder (PDAP) (Nixdorf & Moana-Filho 
2011, Nixdorf et al. 2012), phantom tooth pain (Marbach 1978), and painful 
post traumatic trigeminal neuropathy (PPTTN, International Classification of 
Headache Disorders 3 [ICHD-3]) (Benoliel et al. 2012a, Benoliel et al. 2012b, 
  
IHS 2013, IHS 2018). Given the uncertainty regarding its nomenclature, 
pathophysiology, and disease course, the two most common terms used in 
the literature to refer to the phenomenon will be used throughout this paper: 
Atypical Odontalgia and Persistent Dentoalveolar Pain disorder (AO/PDAP).  
 
Individuals experiencing AO/PDAP following deafferentation procedures are 
unlikely to experience pain reduction with endodontic non-surgical 
retreatment, or further surgical intervention (Marbach 1978, Oshima et al. 
2009). It is important, therefore, to identify AO/PDAP cases early in their 
course thereby preventing any further dental treatments that are irreversible, 
ineffective, and may contribute to worsening morbidity (Durham & Nixdorf 
2014, Durham & Nixdorf 2014).  A brief standardized AO/PDAP screening 
instrument would be a practical way to begin the process of identification of 
putative AO/PDAP cases. This approach would parallel similar approaches to 
screening for other conditions in medicine and dentistry (Maizels et al. 2006, 
Price et al. 2010, Schiffman et al. 2014). Screening instruments for 
neuropathic pain in medical clinics have become accepted clinical practice 
due to a number of factors including the inherent complexity of diagnosing 
neuropathic pain (Bennett et al. 2007). The same complexity exists within 
dental clinics and orofacial pain and therefore it is likely that dental practice 
could similarly benefit from a such a screening instrument.   
 
To date, three studies have examined the use of general (i.e. not restricted to 
orofacial conditions) neuropathic pain screening instruments in screening 
  
orofacial pain (Klasser et al. 2011, Elias et al. 2014, Herrero Babiloni et al. 
2017). In patients with a post-traumatic inferior alveolar or lingual nerve injury, 
the PAINdetect instrument lacked sensitivity for trigeminal neuropathy (Elias 
et al. 2014). Two other studies used a modified version of the Self-completed 
Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) 
questionnaire (Klasser et al. 2011, Herrero Babiloni et al. 2017) with its 
performance being superior to PAINdetect but still lacking sufficient sensitivity 
and specificity in AO/PDAP.  
 
The orofacial region has unique symptom characteristics and nociception from 
this region is mainly conducted by the trigeminal nerve.  Given that the 
trigeminal nerve innervates specialized structures and has unique 
somatosensory properties, nociception from the orofacial region may be 
perceived, interpreted and/or reported differently than nociception from other 
persistent pain conditions elsewhere in the body (Schnurr & Brooke 1992, 
Dworkin 1999, Bereiter et al. 2000). This may account for the limitations 
apparent in the adaptation of more generic whole-body neuropathic screening 
instruments, such as S-LANSS, into the dental setting (Herrero Babiloni et al. 
2017). Given this, an ongoing programme of work (Durham et al. 2013, 
Durham & Nixdorf 2014) has examined the characteristics and impacts of 
AO/PDAP from the patient’s perspective in order to identify items for a self-
report screening instrument (Durham et al. 2013). The aim of the current 
study was to develop and preliminarily evaluate the screening instrument’s 
performance in detecting AO/PDAP amongst a heterogeneous group of 
orofacial pain conditions and pain-free controls and empirically compare its 
  
performance with an established neuropathic screening instrument (S-
LANSS) which is the best available standard.   
  
Materials and Methods 
Ethical approval was obtained (University of Minnesota IRB: 1104S98353) 
and written, informed consent obtained from all participants. The present 
report follows the Standards for Reporting of Diagnostic Accuracy (STARD) 
(Bossuyt et al. 2003). 
 
Participants and procedures 
This study was cross-sectional and utilised a convenience sample of 
AO/PDAP patients, three other orofacial pain conditions, and a pain-free 
control group. The three groups of other orofacial pain conditions were: 
temporomandibular disorders (TMD), trigeminal neuralgia, and acute dental 
pain. The three other orofacial pain conditions were chosen on the basis of 
the likelihood that they may mimic AO/PDAP and thereby provide a more 
exacting test of the screening instrument. All of the TMD and TN patients, and 
the majority of AO/PDAP patients were recruited from the TMD, Orofacial 
Pain and Dental Sleep Medicine Clinic (University of Minnesota, USA). Two of 
the AO/PDAP patients were recruited from private orofacial pain practice 
(Minneapolis-Saint Paul, MN). Patients experiencing acute dental pain were 
recruited from a private endodontic practice, (Minneapolis-Saint Paul, MN). 
The pain-free controls were recruited by approaching accompanying persons 
at the School of Dentistry (University of Minnesota, MN) and people in the 
university community.  
The following inclusion criteria applied to all study participants: 
• Eighteen years of age or older; 
  
• Ability to converse fluently in English; 
• Met the diagnostic criteria for the respective group assignment. 
The exclusion criteria for the study were: 
• Unable to provide informed consent; 
• Any history of trauma to the orofacial region throughout their life 
course; 
• Any history of TMJ surgery or intra-articular steroid injection; 
• Any lifetime history of a major systemic illness related to altered 
pain sensitivity, for example fibromyalgia or other widespread 
bodily pains (even if resolved). 
 
Assignment to the AO/PDAP group was based on each participant meeting 
the diagnostic criteria for AO, PDAP, and PPTTN (Table e1, Appendix) and 
having all other potential causes of the pain phenomenon excluded by 
appropriate (clinical) investigation (Woda & Pionchon 1999, IHS 2004, Nixdorf 
& Moana-Filho 2011, Nixdorf et al. 2012, IHS 2013, IHS 2018). Classification 
was performed by an experienced board-certified clinicians who were trained 
and calibrated in a previous study (Nixdorf et al. 2015).  
 
For the other three orofacial pain conditions, reference standard criteria were 
followed. Assignment to the painful TMD sample was based on myalgia, 
myofascial pain, or arthralgia, according to Diagnostic Criteria for TMD 
(DC/TMD) (Schiffman et al. 2014). Assignment to the acute dental pain group 
was based on the diagnostic criteria of Gutmann et al. (2009) pertaining to 
  
irreversible pulpitis and/or symptomatic apical periodontitis applied by a 
specialist board-certified endodontist (Nixdorf et al. 2015). Assignment to the 
Trigeminal Neuralgia sample was based on use of the ICHD-II Diagnostic 
Criteria for the diagnosis of Classical Trigeminal Neuralgia (IHS 2004). Pain-
free controls confirmed that they had no pain in the face, mouth, teeth, jaws, 
or ears in the last three months; and had not sought dental treatment within 
the last three months. 
 
A total of six instruments, including the AO/PDAP screening instrument, were 
presented individually to the participants in a predetermined randomised 
sequence (permuted block). Putative participants were flagged by the clinical 
team to research team members uninvolved in the patient’s care and they 
then gave a standardised explanation of the instruments to the participant. 
Participants were recompensed $20 U.S. for the time it took to complete the 
instruments.  
 
Measures and instruments 
A case report form was completed by the clinical team, recording individuals’ 
socioeconomic/demographic status and clinical diagnosis. Besides the 
AO/PDAP screening instrument, the modified Self-completed Leeds 
Assessment of Neuropathic Symptoms and Signs (S-LANSS) was also 
completed as a reference to allow an empirical comparison for the 
performance of the AO/PDAP screening instrument. S-LANSS was chosen in 
preference to the next most common generic neuropathic pain-screening 
  
instrument because it has good sensitivity and specificity for general 
neuropathic pain (Bennett et al. 2005) whereas the PainDETECT 
demonstrated poor sensitivity for trigeminal neuropathy (Elias et al. 2014). 
 
The putative full fourteen-item AO/PDAP screening instrument examined in 
this study is outlined in supplemental Figure e1. Nine of its fourteen items 
were constructed from the recurring themes in a previously reported 
qualitative research study regarding patients suffering from AO/PDAP 
(Durham & Nixdorf 2014). These nine items (“AO/PDAP specific items” Q1,6-
11,13-14, in Figure e1) were worded to mirror the terms used by participants 
in the qualitative study in order to ensure sufficient face validity for American 
English speakers. The remaining five items (Q2,3,4,5,12), giving rise to the 
14-item instrument, were added based on expert opinion of two board-
certified orofacial pain clinicians (JD & DRN) in order to increase the 
specificity of the instrument in relation to the other common orofacial pain 
conditions (TMD, TN, Acute dental pain). The AO/PDAP screening instrument 
was given a standard bipolar scoring system of:  -2 strongly disagree to 2 
strongly agree, with neither agree nor disagree scored as 0. Items 3,4,5, and 
12 were reverse scored. A simple sum of the item scores was used to 
generate a summary score. 
 
The S-LANSS used in the study was adapted for use intra-orally (Klasser et 
al. 2011), by relating each S-LANSS item to intraoral tissues as described in 
full by Herrero Babiloni et al. (2017). The scoring system and threshold values 
  
for a positive response to the items (≥12) remained the same as the original 
S-LANSS (Bennett et al. 2005), consistent with Klasser et al. (2011). 
 
Data management and analysis 
All data were inputted into Microsoft Excel (Microsoft Excel 2010, Microsoft 
Corporation, Redmond, Washington) by research team members uninvolved 
in the participants’ care and the data were then crosschecked for 
concordance (DRN/JD). There were no missing data in the subjects who 
comprised the sample used for analysis. Simple descriptive statistics and 
inferential parametric statistics were used to examine the data. For between-
group comparisons, family-wise Bonferroni correction to the p-value was 
used. In all other cases, the significance level was set to alpha=0.05. All 
analyses were performed using STATA release 13 (Stata Statistical Software. 
StataCorp LP, College Station, TX, USA). The analyses were divided into two 
phases: in the first phase, only the 9 AO/PDAP specific items were assessed, 
while in the second phase, all 14 items were included in the analyses.  
 
Phase 1 – internal reliability (Cronbach’s alpha) was calculated for the nine 
AO/PDAP specific items. Exploratory factor analysis was then used to identify 
whether these nine AO/PDAP specific items were unidimensional. The 
exploratory factor analysis was conducted using principal factor analysis with 
a polychoric correlation matrix and excluding the control group (as they have 
no orofacial pain). The number of factors to be retained was determined from 
the point of inflexion in the scree plot and a second exploratory factor analysis 
  
retaining all factors with an eigenvalue>1.0 provided a comparison analysis. 
Finally, in Phase 1, the ability of the AO/PDAP specific items to differentiate 
cases (those with AO/PDAP) from all comparison groups was examined. We 
used the standard bipolar simple scoring system to calculate a summary 
score for the nine AO/PDAP specific items and then used this score in a ROC 
analysis to determine the most appropriate threshold for a positive screening 
for AO/PDAP (a 'true positive') and its resultant sensitivity and specificity. This 
performance was empirically compared to that of the S-LANSS in determining 
an AO/PDAP case from a comparator. Convergent validity of the summary 
score of the nine AO/PDAP specific items and the S-LANSS’ summary score 
was also assessed using a Pearson correlation. 
 
Phase 2 - the putative full 14-item AO/PDAP screening instrument was 
subject to another exploratory factor analysis using the same principal factor 
approach and matrix. Poorly performing items (i.e. those with factors loadings 
<±0.4 (Matsunaga 2010) or cross-loadings of ³±0.4 on two or more factors) 
were removed. Once the final item list was established, a new ROC analysis 
of the revised items’ summary score was computed to determine the 
threshold for a positive screening for AO/PDAP and its resultant sensitivity 
and specificity.  
  
  
Results 
The sociodemographics of the sample and their diagnoses are provided in 
Table 1. The patients were predominately female (72%), with a mean age of 
49 (SD±16) years old. Table e2 in the appendix contains specific details on 
the characteristics of the AO/PDAP cohort. The mean summary standard 
score per instrument by condition is shown in Table 2 and a one-way ANOVA 
demonstrated that the conditions differ in their AO/PDAP screening instrument 
score. Supplemental Table e3 displays the mean scores by item of the 
AO/PDAP screening instrument. 
 
Phase 1 - Cronbach’s alpha for the nine AO/PDAP specific items using a 
simple summary score was 0.83. The exploratory factor analysis returned a 
single-factor solution that explained 61% of the total variance (Table 3 and 
Table e4 for polychoric correlation matrix) even after exploring other factor 
structures with oblique rotation. Items 6 and 9 did, however, have very poor 
loadings on the single factor. 
 
The AO/PDAP specific nine-item simple summary score moderately 
correlated with the S-LANSS summary score (r=0.58; p<0.01). The ROC 
analysis for the AO/PDAP specific items’ summary score demonstrated the 
optimum threshold as ≥3 (ROC area=0.71; 95%CI: 0.60-0.81). The sensitivity 
and specificity for the AO/PDAP specific items at this threshold and that of the 
S-LANSS at its standard threshold along with their confidence intervals with 
the true positive being a clinically-determined AO/PDAP diagnosis are shown 
  
in Table 4. Compared to the AO/PDAP specific nine-item summary score, S-
LANSS had better specificity (78%) but lower sensitivity (32%).  
 
Phase 2 – Following the addition of the five expert-derived items the 
exploratory factor analysis of the now 14-item instrument returned a three-
factor structure with a weak third factor (Eigen value 1.02) explaining 87% of 
the variance. Three factors were retained and oblique rotation performed 
(Table e5 appendix) and subsequently two items were removed for weak 
loading on all factors: item 7 “times when pain intensity increases”, and item 
12 “better with over-the-counter pain medications…”. Re-running the 
exploratory factor analysis on the remaining 12 items demonstrated a two-
factor structure explaining 82% of the variance (Table e6 appendix).  
 
An iterative process explored the remaining factor structures related to the 
other items that either: had loaded heavily on the third factor (items 5 “best 
described as sharp, stabbing, or electrical” and 6 “generally a dull ache”); or 
cross-loaded in the three-factor model (items 1 “pain never stops” and 9 “able 
to locate the pain accurately”). The factor structure that best explained the 
majority of the variance (96%) was a two-factor model that dropped items 6 
and 9 in addition to items 7 and 12 that had been dropped in the previous 
iteration. The remaining 10-item screening instrument is shown in the 
appendix (Table e7) and a final version for clinical use is shown in Figure e2 . 
 
  
The ROC area of the 10-item finalised AO/PDAP screening instrument was 
0.77 (95%CI: 0.67; 0.88) and demonstrated the optimum threshold for the 
summary score as ≥1. The 10-item AO/PDAP screening instrument (appendix 
figure e2) improved the point estimates of sensitivity and specificity of the 
instrument compared to the AO/PDAP specific nine-item version (Table 4) 
with Cronbach’s alpha calculated at 0.83.  
  
  
Discussion 
In this study, development of the AO/PDAP screening instrument and a 
preliminary evaluation of its performance in detecting cases of AO/PDAP in a 
convenience sample was performed. Our results suggest that the final 10-item 
AO/PDAP screening instrument measures 2 constructs and has modest 
sensitivity of 77% (95% CI: 55%-92%) and specificity of 69% (95% CI: 60%-
77%). Empirically this compares favourably to the S-LANSS: sensitivity 32% 
(95% CI: 14%-55%), specificity 78% (95% CI: 70%-85%), and the nine 
AO/PDAP-specific items within the screening instrument also had a moderate 
convergent validity with the S-LANSS (r=0.58; p<0.01). The sensitivity and 
specificity point estimates suggest that as long as the AO/PDAP screening 
instrument is used with prudence alongside standard clinical investigation and 
examination it represents one way by which those without orofacial pain 
expertise can increase their diagnostic suspicion of AO/PDAP following 
treatments involving deafferentation. 
 
The challenge of screening for AO/PDAP involves differentiating between 
multiple and potentially comorbid conditions producing pain within the 
orofacial region.  A useful screening tool must contain items identifying key 
(diagnostic) features of the condition in question. With AO/PDAP, this is more 
challenging, as the disorder is underreported, poorly understood, and the 
idiosyncrasies of the condition had not been accurately detailed before recent 
qualitative research (Durham & Nixdorf 2014). This qualitative research 
helped define the key recurrent characteristics of the pain associated with 
AO/PDAP, which were then used to help produce the AO/PDAP-specific items 
  
within the screening instrument. These characteristics are covered elsewhere 
(Durham et al. 2013), but briefly they are: constant nature; low intensity with 
variability producing acute exacerbations; pressure-like phenomenon felt deep 
within bone or tooth; adjunctive features such as itchiness, prickling, or 
tingling.  
 
As a preliminary evaluation of the screening instrument this study has 
limitations. The methodology used didn’t seek to confirm content validity; 
however the nine items derived from patients (Durham & Nixdorf 2014) do 
provide a patient-centred approach. The other properties that are yet to be 
examined include face validity, test-retest reliability, and responsiveness to 
change. Further validity studies are required in other languages in order to 
ensure that the constructs of each statement remain semantically and 
culturally relevant to the target population; this is particularly relevant given 
the complex symptom characteristics. Future studies will also provide 
independent datasets with which to re-examine the current study’s estimates 
of the instrument’s sensitivity and specificity as it is possible given the current 
study refined and tested the instrument using the same dataset the estimates 
of sensitivity and specificity may be inflated. 
 
 
The study remuneration was provided as a token of our appreciation of the 
time participants spent completing the study documentation. It is conceivable, 
however, that despite its low value it influenced individuals’ responses, but we 
  
believe this is unlikely given they were unaware of which questionnaires 
related to which condition. Despite recruiting for a considerable period of time 
and offering a gratuity, the limited number of individuals (n=22) in the 
AO/PDAP group is indicative of its low prevalence and therefore the difficulty 
of recruiting such individuals. A future direction to address both sample size 
and cultural differences would be to conduct such research across countries 
with the participation of multiple clinical research groups, such as with the use 
of a registry of patients suffering from AO/PDAP. The convenience sample 
was selected to give the instrument the broadest and most exacting 
evaluation but does not replicate the reality of everyday clinical practice. It is 
conceivable that the point estimates of sensitivity and specificity for the 
instrument may increase or decrease in routine practice settings hence further 
field testing is required. Furthermore any future field testing should seek to 
control bias in a rigorous manner. 
 
At present, the authors suggest that the AO/PDAP screening instrument, 
produces sufficient sensitivity and specificity (77% and 69% respectively), to 
represent a step-forward for identifying putative AO/PDAP cases that may 
need specialist examination prior to any further investigation or intervention. 
The AO/PDAP screening instrument will, however, be prone to false positives 
and practitioners should bear this in mind when using it and ensure they use 
all the clinical information at their disposal before making a putative positive 
screen for AO/PDAP using the finalised ten item screen shown in Appendix 
Figure e2. It may be that with the recent emergence of the utility of qualitative 
sensory testing in differentiating AO/PDAP from controls (Baad-Hansen et al. 
  
2013a, Baad-Hansen et al. 2013b) that the combination of somatosensory 
changes (gain or loss in cold, light touch, pin-prick) detected by qualitative 
sensory testing chairside and the use of the screening instrument may 
present an opportunity for a step change in the diagnosis of AO/PDAP which 
currently is a diagnosis of exclusion. 
 
In a general dentistry setting, the use of the AO/PDAP screening instrument is 
particularly desirable because dentists are comfortable diagnosing 
odontogenic pain but generally may be less comfortable with non-odontogenic 
pains. The current psychometric properties of the AO/PDAP screening 
instrument represent an acceptable trade-off between sensitivity and 
specificity as they will help decrease morbidity through non-productive dental 
treatment for a problem that is no longer dental. The authors would 
recommend, therefore, that best use of the AO/PDAP screening instrument is 
as an adjunct to the regular diagnostic process when signs, symptoms, and 
investigations do not clearly indicate an odontogenic or TMD as source for the 
patient’s “tooth” pain complaint. Given the nature and origins of the screening 
instrument it will screen for any of AO, PDAP, or PPTTN as the samples used 
in its development included participants who fitted the criteria for all of these 
conditions.  
 
Conclusion 
Given the current options available to help with identifying AO/PDAP early in 
its course following deafferentation treatments the AO/PDAP Screener has 
  
sufficient sensitivity and specificity to begin field testing on a larger and 
multinational scale. It must, however, be used alongside careful and 
appropriate clinical examination and investigation. 
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Supporting information 
There is an appendix document which contains 2 figures and 7 tables in order 
to give the reader further details on both the instrument and the data collected. 
This singular word document is meant for viewing online via the journal’s 
website.  
  
Tables 
Table 1 – Sample socioeconomic and demographic status 
 
Control 
n=21 
AO/ 
PDAP 
n=22 
TN 
n=21 
TMD 
n=41 
ADP 
n=41 
Total 
n=146 
Gender n(%) 
      
Female 13(62) 20(91) 14(67) 35(85) 23(56) 105(72) 
Male 8(38) 2(9) 7(33) 6(15) 18(44) 41(28) 
       
Age Mean(SD) 45(14) 52(12) 60(18) 45(17) 48(12) 49(16) 
       
Race n(%) 
      
White 19(90) 22(100) 20(95) 37(90) 32(78) 130(89) 
Black or African 
American 0(0) 0(0) 0(0) 2(5) 3(7) 5(3) 
Other 2(10) 0(0) 1(5) 2(5) 6(15) 11(8) 
       
Income n(%)a 
      
<$10,000 2(10) 2(9) 5(24) 10(24) 3(7) 22(15) 
$10,000-$29,999 3(15) 2(9) 2(10) 12(29) 3(7) 22(15) 
 $30,000-49,999 4(20) 6(27) 6(29) 3(7) 11(27) 30(21) 
≥$50,000 11(55) 12(55) 8(38) 16(39) 24(59) 71(49) 
       
Level of 
education n(%) 
      
Pre High and 
High School  0(0) 5 (23) 3 (14) 7 (17) 6 (15) 21 (14) 
Some college 2(10) 1(5) 7(33) 13(32) 13(32) 36(25) 
College degree  4(19) 6(27) 5(24) 18(44) 14(34) 47(32) 
Advanced or 
graduate degree 15(71) 10(45) 6(29) 3(7) 8(20) 42(29) 
       
Dental Insurance 
n(%) 
      
Uninsured 7(33) 1(5) 8(38) 7(17) 4(10) 27(18) 
Insured 14(67) 21(95) 13(62) 34(83) 37(90) 119(82) 
a) 1 individual did not declare their income bracket 
TN – Trigeminal neuralgia; TMD  - Temporomandibular Disorders;  ADP – Acute Dental Pain;  
AO/PDAP – Atypical Odontalgia/Persistent DentoAlveolar Pain Disorder
  
Table 2 – Mean scores by instrument and by pain condition 
 
Clinical 
diagnosis 
AO/PDAP screening 
instrument*  
[95% CI] 
S-LANSS Mean 
Score  
[95% CI] 
Control -7.05 a,b 0 c 
 
[-8.07; -6.02] [0.00; 0.00] 
AO/PDAP 6.73a 10.59 c 
 
[4.53; 8.93] [7.83; 13.35] 
TN 0.86 b 9.52 c 
 
[-1.02; 2.73] [6.45; 12.59] 
TMD 3 b 7.27 c, d 
 
[1.54; 4.46] [5.17; 9.37] 
ADP 1 b 11.05 c, d 
 
[-0.47; 2.47] [8.93; 13.17] 
* Full fourteen item version of AO/PDAP Screener mean simple summary score using bipolar scoring 
aOne-way ANOVA with post hoc Bonferroni correction significantly higher scores in AO/PDAP cases 
compared to controls, ADP (F(4,141)=36.52, p<0.001) 
bOne-way ANOVA with post hoc Bonferroni correction significantly higher scores in TN, TMD, and ADP 
cases than in controls (F(4,141)=36.52, p<0.001).  
cOne-way ANOVA with post hoc Bonferroni correction significantly higher scores in AO/PDAP, TN, 
TMD, and ADP cases than in controls (F(4,141)=12.77, p<0.0001);  
dOne-way ANOVA with post hoc Bonferroni correction significantly higher scores in ADP cases 
compared to TMD cases (F(4,141)=12.77, p<0.05). 
TN – Trigeminal neuralgia; TMD  - Temporomandibular Disorders;  ADP – Acute Dental Pain;  
AO/PDAP – Atypical Odontalgia/Persistent DentoAlveolar Pain Disord
  
Table 3 – Principal factor analysis for nine AO/PDAP specific items 
using standard bipolar scoring system 
 
Item 
Principal factor analysis  
Factor 
loading 
   
Uniqueness  
1. This pain never stops; it seems to always be there. 0.52 0.73 
6. This pain is generally a dull ache.  0.06 0.99 
7. There can be times when the pain intensity increases 
(pain attack) and then it returns to its usual level. 0.44 0.81 
8. This pain gets worse with changes of atmospheric 
pressure, for example during bad weather, scuba diving, 
airplane travel. 0.32 0.90 
9. I feel I am able to locate the pain accurately, for example 
to a particular tooth or small area in my mouth. 0.08 0.99 
10. This pain feels like it is deep within the tooth or jaw 
bone. 0.54 0.71 
11. This pain feels like a pressure within the tooth or jaw 
bone 0.53 0.72 
13. This pain is difficult for me to describe to others.  0.51 0.74 
14. Some words that might help describe my pain include 
peculiar: itchy, tingling, or prickling feelings. 0.28 0.91 
Kaiser-Meyer-Olkin measure of sampling adequacy = 0.827 
Bartlett's test of sphericity 2=407.18; df=36; p=0 
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Table 4 – Sensitivity and specificity of AO/PDAP screening instrument in 
9 and 10 item forms, and S-LANSS summary score 
 
 
Sensitivity 
 
Specificity 
 
 
Point 
estimate 95% CI 
Point 
estimate 95% CI 
AO/PDAP-specific nine items simple 
summary score using bipolar scoring 
system (threshold ≥3) 68% 
45%     
86% 58% 
49%     
67% 
AO/PDAP screening instrument (10 
items) simple summary score using 
bipolar scoring system per item 
(threshold ≥1) 77% 
55%     
92% 69% 
60%     
77% 
S-LANSS (threshold ≥12) 32% 
14%     
55% 78% 
70%     
85% 
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Supplemental information and appendix: 
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Supplementary Figure e1 - Full fourteen item AO/PDAP Screener 
1. This pain never stops; it seems to always be there. 
 
     
2. This pain moves around, sometimes it seems to be mainly in one area and at other times it 
seems to be in other areas. 
     
3. This pain is a throbbing type of pain. 
 
4. This pain wakes me up at night. 
 
     
5. This pain is best described as sharp, stabbing, or electrical bouts of pain that are intense, 
brief in duration (lasting for seconds or less). 
 
     
6. This pain is generally a dull ache. 
 
     
7. There can be times when the pain intensity increases (pain attack) and then it returns to its 
usual level.  
 
     
8. This pain gets worse with changes of atmospheric pressure, for example during bad weather, 
scuba diving, airplane travel.   
 
    
9. I feel I am able to locate the pain accurately, for example to a particular tooth or small area 
in my mouth. 
 
     
10. This pain feels like it is deep within the tooth or jaw bone.  
      
11. This pain feels like a pressure within the tooth or jaw bone.  
      
12. This pain is made better with taking over the counter “pain medications”, such as ibuprofen. 
     
13. This pain is difficult for me to describe to others. 
 
14. Some words that might help describe my pain include peculiar: itchy, tingling, or prickling 
feelings. 
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Supplementary Figure e2 – Finalised ten item AO/PDAP screener for 
clinical use. 
 
• Please leave NO question unanswered 
 
• Please    CIRCLE   your response to the question using the response 
options provided underneath each question: strongly disagree, 
disagree, neither agree nor disagree, strongly agree, agree 
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1. This pain never stops; it seems to always be there. 
 
     
2. This pain moves around, sometimes it seems to be mainly in one area and at other times it 
seems to be in other areas. 
 
     
3. This pain is a throbbing type of pain. 
 
4. This pain wakes me up at night. 
 
     
5. This pain is best described as sharp, stabbing, or electrical bouts of pain that are intense, 
brief in duration (lasting for seconds or less). 
     
6. This pain gets worse with changes of atmospheric pressure, for example during bad weather, 
scuba diving, airplane travel.   
 
     
7. This pain feels like it is deep within the tooth or jaw bone.  
      
8. This pain feels like a pressure within the tooth or jaw bone.  
     
9. This pain is difficult for me to describe to others. 
 
10. Some words that might help describe my pain include peculiar: itchy, tingling, or prickling 
feelings. 
 
There are NO more questions to answer in this booklet, thank you
  33 
For office use (remove this text prior to issuing the instrument to 
patients): 
Scoring instructions: 
 
 -2 to 2 for strongly disagree to strongly agree for all items except for 3, 4, 
and 5 where reverse scoring is used (i.e. strongly agree is -2 and strongly 
disagree is 2). 
 
To calculate the total score for the AO/PDAP screening instrument we 
recommend the simple sum method whereby the response scores of all 
items are summed. The threshold for a positive screen is ≥1.  
 
The interpretation of the AO/PDAP screening instrument’s threshold score 
being met or exceeded is that it is not likely that the pain is from an 
odontogenic or TMD cause. Therefore, neuropathic or idiopathic aetiologies 
may be present and further investigation is warranted. 
 
Below is a scored example of the AO/PDAP screening instrument (* 
indicates reverse scoring item): 
Item Response given Score 
1 Strongly agree 2 
2 Agree 1 
3* Neither agree nor 
disagree 
0 
4* Disagree 1 
5* Strongly disagree 2 
6 Neither agree nor 
disagree 
0 
7 Strongly disagree -2 
8 Strongly agree 2 
9 Neither agree nor 
disagree 
0 
10 Strongly agree 2 
Total score (sum) 8 
 
Interpretation of score: Exceeds threshold of 1 and therefore patient’s pain is 
not likely to be of odontogenic or TMD aetiology. 
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Supplementary Table e1 – Diagnostic criteria for Atypical odontalgia (AO), Persistent Dentoalveolar Pain disorder 
(PDAP), and Painful Post Traumatic Trigeminal Neuropathy (PPTTN) (IHS 2004, Nixdorf et al. 2012, IHS 2013, IHS 2018) 
 
Condition Summary of diagnostic criteria as they relate to phenomenon of interest for this study 
 
Atypical odontalgia 
 
1. Pain is localized to a tooth that is present in the mouth or has recently been extracted. 
2. Pain has been present for the last 4 to 6 months or has returned periodically in the same form over 
the last period of months or years. 
3. Pain is continuous throughout all or part of the day except during sleep. 
4. The pain has no major paroxysmal character. 
5. Clinical or radiographic examination does not reveal any obvious cause of pain. 
Painful Post Traumatic Trigeminal Neuropathy  
 
A. Facial and/or oral pain in the distribution(s) of one or both trigeminal nerve(s) and fulfilling criterion C 
B. History of an identifiable traumatic event to the trigeminal nerve(s), with clinically evident positive 
(hyperalgesia, allodynia) and/or negative (hypoaesthesia, hypoalgesia) signs of trigeminal nerve 
dysfunction 
C. Evidence of causation demonstrated by both of the following: 
1. pain is localized to the distribution(s) of the trigeminal nerve(s) affected by the traumatic event 
2. pain has developed < 6 months after the traumatic event 
D. Not better accounted for by another ICHD-3 diagnosis. 
Persistent dentoalveolar pain (PDAP) - Secondary 
 
1. Persistent pain (at least 8hrs per day for ≥15days per month). Present for ≥3 months 
2. Localised in the dentoalveolar region(s) 
3. Not caused by another disease or disorder 
4. In close temporal relationship to a causal event (e.g. dental procedures, facial trauma, infection,…) 
5. Sensory abnormality present or absent 
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Supplementary Table e2 - Characteristics of AO/PDAP cohort and final screener score 
Case 
id* Age Gender Level of education 
Tooth site. 
Universal/USA 
system 
(FDI/Canadian 
system) 
Dental 
Arch Tooth Type 
Deafferentation 
preceding pain 
RCT of 
painful 
tooth 
Total n 
of RCT 
to 
painful 
tooth 
Painful 
tooth 
extracted 
prior to 
clinic 
visit 
Finalised 
10 item 
screener 
summary 
score‡ 
1 66 Female Advance/Graduate Degree 9 (21) Mx Central incisor Yes Yes 1 No 1 
2 51 Female Advance/Graduate Degree 9 (21) Mx Central incisor Yes Yes 2 Yes 3 
3 28 Female Advance/Graduate Degree 19 (36) Mn 1st molar No† No 0 No -8 
4 28 Male College Degree 3 (16) Mx 1st molar Yes Yes 1 Yes 9 
5 66 Female High School Missing data 4 
6 42 Female College Degree 14 (26) Mx 1st molar Yes Yes 1 Yes 3 
7 57 Female Advance/Graduate Degree 5 (14) Mx 1st premolar Yes Yes 4 Yes 3 
8 49 Female Advance/Graduate Degree 5 (14) Mx 1st premolar Yes Yes 3 No 5 
9 63 Female High School 11 (23) Mx Canine Yes Yes 2 No 9 
10 59 Female Advance/Graduate Degree 4 (15) Mx 2nd premolar Yes Yes 1 No -1 
11 58 Female High School 7 (12) Mx Lateral incisor Yes Yes 1 Yes 0 
12 37 Female College Degree 14 (26) Mx 1st molar No† No 0 No 2 
13 60 Female College Degree 13 (25) Mx 2nd premolar Yes Yes 2 No -1 
14 35 Female College Degree Missing data 1 
15 65 Male Some College 10 (22) Mx Lateral incisor Yes Yes 2 Yes 2 
16 56 Female Advance/Graduate Degree 9 (21) Mx Central incisor Yes Yes 2 No -4 
17 57 Female High School 29 (45) Mn 2nd premolar Yes Yes 2 No 8 
18 46 Female Advance/Graduate Degree 3 (16) Mx 1st molar Yes Yes 1 Yes 9 
19 64 Female Advance/Graduate Degree 3 (16) Mx 1st molar Yes Yes 1 No 1 
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Case 
id* Age Gender Level of education 
Tooth site. 
Universal/USA 
system 
(FDI/Canadian 
system) 
Dental 
Arch Tooth Type 
Deafferentation 
preceding pain 
RCT of 
painful 
tooth 
Total n 
of RCT 
to 
painful 
tooth 
Painful 
tooth 
extracted 
prior to 
clinic 
visit 
Finalised 
10 item 
screener 
summary 
score‡ 
20 66 Female High School 12 (24) Mx 1st premolar Yes Yes 2 No 5 
21 48 Female Advance/Graduate Degree 7 (12) Mx Lateral incisor Yes Yes 2 No 5 
22 42 Female College Degree 14 (26) Mx 1st molar Yes Yes 2 Yes 3 
RCT – Root canal treatment; Mx – maxillary dentition; Mn Mandibular dentition. 
* All cases were of white ethnic origin and all had cone-beam computed tomography of the painful site/tooth and also a brain and face MRI to exclude other pathology.  
†Both of these cases had experienced a traumatic event affecting the tooth in question within 3-6 months of the pain beginning and therefore fitted PPTTN diagnostic criteria 
(Appendix table e1)  
‡ Scores of individual cases from the finalised 10 item screener (Figure e2). Emboldened figures are where the case failed to meet the threshold for a positive screen (≥1). Given 
the heterogeneity of the phenomenon under investigation and the idiosyncratic nature of the experience and description of pain this variation is to be expected. 
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Supplementary Table e3 – Simple ordinal mean scores by item of AO/PDAP screener 
Study 
group Control	 AO/PDAP	 TN	 TMD	 ADP	
Item 
number Mean score 
	95% 
Confidence 
interval 
Mean score 
	95% 
Confidence 
interval	 Mean score 	95% Confidence interval	 Mean score 	95% Confidence interval	 Mean score 	95% Confidence interval	
1 -3.62 [-4.17;-3.07] 2 [1.01;2.99] -0.67 [-1.96;0.63] 0.24 [-0.68;1.17] 0 [-0.85;0.85] 
2 1.9 [1.71;2.10] 0.55 [-0.12;1.21] -0.52 [-1.21;0.16] -0.07 [-0.54;0.40] -0.1 [-0.55;0.35] 
3 1.9 [1.71;2.10] 0.18 [-0.38;0.74] 0.24 [-0.34;0.81] 0.05 [-0.41;0.51] -0.54 [-0.95;-0.12] 
4 1.9 [1.71;2.10] 0.32 [-0.20;0.84] 0.29 [-0.34;0.92] 0.41 [0.00;0.83] -0.32 [-0.78;0.14] 
5 1.9 [1.71;2.10] 1.18 [0.66;1.71] -1.24 [-1.73;-0.74] 0.54 [0.11;0.97] 0.27 [-0.18;0.71] 
6 -3.81 [-4.21;-3.41] 1.82 [0.87;2.76] -0.19 [-1.26;0.88] 1.61 [0.98;2.24] 0.98 [0.27;1.68] 
7 -1.9 [-2.10;-1.71] 0.45 [-0.17;1.08] 1.05 [0.48;1.61] 0.68 [0.32;1.05] 0.9 [0.54;1.27] 
8 -1.9 [-2.10;-1.71] -0.45 [-1.00;0.09] -0.1 [-0.63;0.44] -0.39 [-0.79;0.01] -0.66 [-0.95;-0.37] 
9 -1.71 [-2.15;-1.28] 0.59 [-0.09;1.27] 0.76 [0.19;1.34] 1.1 [0.75;1.45] 1.02 [0.63;1.42] 
10 -3.81 [-4.21;-3.41] 2.09 [1.12;3.06] 0.86 [-0.35;2.06] 1.27 [0.51;2.03] 1.95 [1.30;2.61] 
11 -1.9 [-2.10;-1.71] 0.45 [-0.11;1.01] -0.29 [-0.92;0.34] 0.27 [-0.13;0.67] 0.71 [0.39;1.02] 
12 1.62 [1.25;1.99] 0.36 [-0.19;0.92] 1 [0.57;1.43] -0.05 [-0.36;0.26] -0.56 [-0.91;-0.21] 
13 -3.05 [-3.84;-2.25] 0.91 [-0.24;2.06] 0.57 [-0.55;1.69] -0.2 [-1.04;0.65] -1.17 [-1.88;-0.47] 
14 -1.71 [-2.04;-1.39] -0.32 [-0.95;0.31] -0.62 [-1.17;-0.07] -1 [-1.35;-0.65] -0.61 [-0.98;-0.24] 
 
AO/PDAP – Atypical odontalgia/persistent DentoAlveolar Pain disorder; TN – Trigeminal Neuralgia; TMD – Temporomandibular Disorder; ADP – Acute dental 
pain
  38 
Supplementary Table e4 – Polychoric correlation matrix from 
exploratory factor analysis of 9 AO/PDAP specific items 
 
Item number  
from the original 14 1 6 7 8 9 10 11 13 14 
1 1.00         
6 0.24 1.00        
7 0.15 0.01 1.00       
8 0.07 0.05 0.31 1.00      
9 0.16 0.19 0.14 -0.20 1.00     
10 0.36 0.12 0.19 -0.10 0.28 1.00    
11 0.21 -0.09 0.14 0.12 0.03 0.51 1.00   
13 0.34 -0.05 0.27 0.33 -0.26 0.06 0.18 1.00  
14 0.09 -0.23 0.20 0.20 -0.09 0.03 0.11 0.26 1.00 
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Supplementary Table e5 – Rotated exploratory factor analysis of putative full fourteen item screener explaining 
87% of variance 
Item and number 
 
Factor Loading Uniqueness 
Factor 
1 
Factor 2 Factor 3 
1. This pain never stops; it seems to always be there. 0.20 0.52 0.51 0.50 
2. This pain moves around, sometimes it seems to be mainly in one area and at other times it seems to be 
in other areas. 0.67 -0.12 -0.04 0.57 
3. This pain is a throbbing type of pain* -0.25 -0.47 0.13 0.60 
4. This pain wakes me up at night* -0.30 -0.44 0.15 0.57 
5. This pain is best described as sharp, stabbing, or electrical bouts of pain that are intense, brief in duration 
(lasting for seconds or less).* -0.03 -0.07 0.75 0.40 
6. This pain is generally a dull ache.  0.03 0.18 0.60 0.65 
7. There can be times when the pain intensity increases (pain attack) and then it returns to its usual level. 0.26† 0.29† -0.20† 0.71 
8. This pain gets worse with changes of atmospheric pressure, for example during bad weather, scuba 
diving, airplane travel. 0.59 0.03 -0.02 0.63 
9. I feel I am able to locate the pain accurately, for example to a particular tooth or small area in my mouth. -0.51 0.42 -0.04 0.70 
10. This pain feels like it is deep within the tooth or jaw bone. -0.23 0.74 0.07 0.50 
11. This pain feels like a pressure within the tooth or jaw bone 0.01 0.58 -0.10 0.63 
12. This pain is made better with taking over the counter “pain medications”, such as ibuprofen.* 0.10† -0.12† 0.17† 0.96 
13. This pain is difficult for me to describe to others.  0.65 0.05 0.16 0.60 
14. Some words that might help describe my pain include peculiar: itchy, tingling, or prickling feelings. 0.35 0.04 -0.19 0.79 
†Poorly performing item across all factors. 
*Items are reverse scored 
Expert derived items are:2,3,4, & 5 
Emboldened figures are strongest factor loading for item 
Italicised figures indicate cross-loading on more than one factor 
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Supplementary Table e6 – Exploratory factor analysis with oblique rotation of interim twelve item screener (items 
7 and 12 dropped because of very poor loadings) explaining 82% of the variance 
Item and number 
 
Factor Loading Uniqueness 
Factor 
1 
Factor 2 
1. This pain never stops; it seems to always be there. 0.30 0.53 0.63 
2. This pain moves around, sometimes it seems to be mainly in one area and at other times it seems to be in 
other areas. 0.47 -0.32 0.68 
3. This pain is a throbbing type of pain* -0.61 -0.14 0.60 
4. This pain wakes me up at night* -0.65 -0.09 0.57 
5. This pain is best described as sharp, stabbing, or electrical bouts of pain that are intense, brief in duration 
(lasting for seconds or less).* -0.39† 0.34† 0.73 
6. This pain is generally a dull ache.  -0.16 0.43 0.79 
8. This pain gets worse with changes of atmospheric pressure, for example during bad weather, scuba diving, 
airplane travel. 0.51 -0.19 0.70 
9. I feel I am able to locate the pain accurately, for example to a particular tooth or small area in my mouth. -0.15 0.44 0.79 
10. This pain feels like it is deep within the tooth or jaw bone. 0.31 0.61 0.54 
11. This pain feels like a pressure within the tooth or jaw bone 0.50 0.33 0.64 
13. This pain is difficult for me to describe to others.  0.51 -0.11 0.73 
14. Some words that might help describe my pain include peculiar: itchy, tingling, or prickling feelings. 0.42 -0.20 0.78 
*Items are reverse scored 
†Poorly performing item across all factors. 
Expert derived items are:2,3,4, & 5 
Emboldened figures are strongest factor loading for item 
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Supplementary Table e7 - Exploratory factor analysis with oblique rotation of ten item screener (items 6,7, 9 and 
12 dropped in first factor analysis because of very poor loadings [7 &12] and cross-loading [6 &9]) explaining 96% 
of the variance 
 
Item and number 
 
Factor Loading Uniqueness 
Factor 
1 
Factor 
2 
1. This pain never stops; it seems to always be there. -0.01 0.56 0.69 
2. This pain moves around, sometimes it seems to be mainly in one area and at other times it seems to be in other 
areas. 0.60 -0.15 0.66 
3. This pain is a throbbing type of pain* -0.44 -0.36 0.60 
4. This pain wakes me up at night* -0.51 -0.31 0.57 
5. This pain is best described as sharp, stabbing, or electrical bouts of pain that are intense, brief in duration (lasting 
for seconds or less).* -0.45 0.12 0.81 
8. This pain gets worse with changes of atmospheric pressure, for example during bad weather, scuba diving, 
airplane travel. 0.61 -0.06 0.64 
10. This pain feels like it is deep within the tooth or jaw bone. -0.12 0.71 0.52 
11. This pain feels like a pressure within the tooth or jaw bone 0.15 0.58 0.59 
13. This pain is difficult for me to describe to others.  0.48 0.09 0.74 
14. Some words that might help describe my pain include peculiar: itchy, tingling, or prickling feelings. 0.46 -0.02 0.79 
*Items are reverse scored 
Expert derived items are:2,3,4, & 5 
Emboldened figures are strongest factor loading for item
  
References 
IHS (2004) The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24 
Suppl 1, 9-160. 
IHS (2013) The International Classification of Headache Disorders 3, (beta version). 
Cephalalgia 33, 629-808. 
IHS (2018) Headache Classification Committee of the International Headache Society (IHS) 
The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38, 1-211. 
Nixdorf DR, Drangsholt MT, Ettlin DA et al. (2012) Classifying orofacial pains: a new proposal 
of taxonomy based on ontology. Journal of Oral Rehabilitation 39, 161-169. 
 
 
